Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo

被引:60
作者
Hamilton, M [1 ]
Wolfman, A [1 ]
机构
[1] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA
关键词
Ras; Raf-1; MAPK; cell proliferation;
D O I
10.1038/sj.onc.1201653
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Ras GTPases function as molecular switches, regulating a multiplicity of biological events, However the contribution, if any, of a specific c-Ras isoform (Ha-, N-, or Ki-ras A or B) in the regulation of a given biological or biochemical process, is unknown, Murine C3H10T1/2 fibroblasts transformed with activated (G12V)Ha-ras or (Q61K)N-ras proliferate in serum-free media and have constitutive MAPK activity, The growth factor antagonist, suramin, inhibited the serum-independent proliferation of Ha-ras transformed fibroblasts, but not the serum-independent proliferation of N-ras transformed cells. The inhibition of cell proliferation was concomitant with the abrogation of the constitutive MAPK activity in the Ha-ras transformed fibroblasts, Analysis of the Ras-signalling complexes in immunoprecipitates from Ha-ras transformed cells revealed that Raf-1 co-immunoprecipitated with endogenous c-N-ras but not (G12V)Ha-ras. Pretreatment with suramin resulted in the loss of Raf-1 from c-N-ras immunoprecipitates, A c-N-ras antisense oligonucleotide, which down-regulated c-N-ras protein levels, abrogated the constitutive MAPK activity and serum-independent proliferation of (G12V)Ha-ras transformed cells, The data suggest that Raf-1 has a higher affinity for N-ras then Ha-ras in vivo, and c-N-ras function is required for the serum-independent proliferation of Ha-ras transformed cells.
引用
收藏
页码:1417 / 1428
页数:12
相关论文
共 58 条
[1]  
Berkowitz EA, 1996, ONCOGENE, V12, P1991
[2]   EFFICIENT REVERSION OF SIMIAN SARCOMA VIRUS-TRANSFORMATION AND INHIBITION OF GROWTH FACTOR-INDUCED MITOGENESIS BY SURAMIN [J].
BETSHOLTZ, C ;
JOHNSSON, A ;
HELDIN, CH ;
WESTERMARK, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (17) :6440-6444
[3]  
CARBONE A, 1991, ONCOGENE, V6, P731
[4]  
CASTELLI C, 1994, CANCER RES, V54, P4785
[5]  
COX AD, 1995, METHOD ENZYMOL, V255, P195
[6]  
CREWS CM, 1993, CELL, V55, P915
[7]  
DAWSON TP, 1995, CANCER RES, V55, P915
[8]   ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE BY V-RAF IN NIH 3T3 CELLS AND INVITRO [J].
DENT, P ;
HASER, W ;
HAYSTEAD, TAJ ;
VINCENT, LA ;
ROBERTS, TM ;
STURGILL, TW .
SCIENCE, 1992, 257 (5075) :1404-1407
[9]   ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY IN TRITON-X-100 DISRUPTED NIH-3T3 CELLS BY P21 RAS AND INVITRO BY PLASMA-MEMBRANES FROM NIH-3T3 CELLS [J].
DENT, P ;
WU, J ;
ROMERO, G ;
VINCENT, LA ;
CASTLE, D ;
STURGILL, TW .
MOLECULAR BIOLOGY OF THE CELL, 1993, 4 (05) :483-493
[10]  
DIBATTISTE D, 1993, ONCOGENE, V8, P637